Why Peptides Need Help Getting Into Your Skin

Peptides are one of the most studied and most widely used ingredients in modern skincare. They appear in serums, creams, eye treatments, and masks across every price point. The science behind why they matter for the appearance of ageing skin is well established. The science behind whether they actually get into your skin when applied topically is considerably less straightforward.

 

This post is about that second question. Specifically: why many peptides struggle to penetrate the skin's outer barrier when applied to the surface, what independent research shows about how micro-infusion technology affects peptide delivery, and why the method of application matters as much as the ingredient itself.

 

This is not a post about what Erra Skin claims. It is a post about what the published science shows, so you can draw your own informed conclusions about how you choose to use peptides in your skincare.

 

The Skin Barrier and Why It Makes Peptide Delivery Difficult

The outermost layer of the skin, known as the stratum corneum, is one of the most effective biological barriers in the human body. Its primary job is to keep the external environment out and internal moisture in. It does this job extremely well, which creates a fundamental challenge for topically applied skincare ingredients: the same barrier that protects your skin from environmental damage also limits what can pass through it.

 

Research in transdermal drug delivery has established what is commonly referred to as the 500 Dalton rule: molecules smaller than approximately 500 Daltons in molecular weight can cross the stratum corneum relatively easily, while larger molecules face significant resistance.

 

Many of the peptides used in high-performance skincare formulations exceed this threshold. Matrixyl 3000, for example, contains two peptide chains with a combined molecular weight that presents a meaningful penetration challenge through intact skin. (Bos & Meinardi, Experimental Dermatology, 2000; Lintner et al., Journal of Cosmetic Dermatology, 2009)

 

 

The second challenge is polarity. The stratum corneum is a lipid-rich, oil-compatible environment. Peptides are hydrophilic molecules, meaning they are water-loving rather than oil-compatible. This creates a chemical mismatch: water-loving molecules moving through an oil-loving barrier.

 

Studies have shown that without modification or a delivery mechanism to assist them, a significant proportion of topically applied peptides remain in the upper layers of the stratum corneum rather than reaching the viable skin below. (Gorouhi & Maibach, International Journal of Cosmetic Science, 2009)

 

 

What Formulation Science Does to Help

It is important to be accurate here: topical peptides are not ineffective. The cosmetic science industry has developed a range of formulation strategies that meaningfully improve peptide penetration without any device assistance.

 

 

Lipophilic modification

One of the most common approaches is bonding peptides to fatty acid chains, such as palmitic acid, to make them more lipid-compatible. This is why you will see ingredients like Palmitoyl Tripeptide-1 (one component of Matrixyl 3000) listed on product labels. The palmitic acid modification improves the peptide's ability to pass through the lipid-rich stratum corneum. (Lintner et al., Journal of Cosmetic Dermatology, 2009)

 

Smaller peptide chains

Shorter amino acid chains, dipeptides and tripeptides, are smaller and more likely to fall below or close to the 500 Dalton threshold. Formulations using shorter chain peptides can achieve meaningful penetration through intact skin without delivery assistance.

 

Surface receptor activity

Some peptides do not need to reach the deeper layers of the skin to be effective. Certain signal peptides can bind to receptors on the surface of skin cells and initiate a response without full transdermal penetration. This is a legitimate and well-documented mechanism of action that does not require a delivery device. (Pickart & Margolina, Frontiers in Aging Neuroscience, 2018)

 

Well-formulated topical peptide products deliver real cosmetic benefits for many users. The limitation is not absolute ineffectiveness but concentration: the amount of active peptide that reaches the viable skin layers through intact barrier skin is typically lower than what reaches the same layers through a delivery-assisted method.

 

What Research Shows About Micro-Infusion and Peptide Delivery

 

 

Micro-infusion technology, inspired by professional microneedling, works by creating temporary micro-channels in the skin through which topically applied ingredients can travel. Rather than relying on passive diffusion through an intact barrier, ingredients delivered through micro-channels have a direct pathway to the skin layers below the stratum corneum.

 

The published research on this mechanism is substantive and consistent in its direction, though it is important to note that study parameters, including needle depth, peptide molecular weight, and formulation type, vary across the literature. Results should be understood in the context of those variables.

 

Improved delivery rates

A review published in the International Journal of Pharmaceutics examined the effect of microneedle-assisted delivery on a range of molecules, including peptides and proteins. The review found that micro-needle delivery improved the penetration of larger molecules by between 2 and 22 times compared to passive topical application, depending on the molecule size, needle length, and application method. It is relevant to note that studies in this review used varying needle depths; results at shallower depths, comparable to cosmetic micro-infusion devices, sit at the lower end of this improvement range. (Nguyen et al., International Journal of Pharmaceutics, PMC11762834, 2025)

 

Bypassing the stratum corneum

Research published in the Journal of Controlled Release demonstrated that micro-channels created by needles at shallow depths, including sub-1mm lengths, were effective in bypassing the stratum corneum and allowing hydrophilic molecules, including peptide analogues, to reach the viable epidermis. The channels remained open for a sufficient duration to allow passive diffusion of applied ingredients during the period immediately following treatment. (Kalluri & Banga, Journal of Controlled Release, 2011)

 

Serum timing and simultaneous delivery

A further study examining the optimal timing of ingredient application in microneedling protocols found that simultaneous delivery, applying the active serum during rather than after needle penetration, produced higher concentrations of active ingredients in the sub-barrier layers compared to post-treatment application. This supports the design rationale behind devices that deliver serum through the needling mechanism rather than as a separate step. (Kim et al., Dermatologic Surgery, 2014)

 

 

 

 

What This Means in Practical Terms

The research does not suggest that topical peptide serums are without value. It suggests that the physical constraints of the skin barrier mean that not all of a topically applied ingredient reaches the layers where it can be most active, and that micro-channel delivery can improve on this.

 

For a cosmetic micro-infusion device operating at 0.5mm depth, the practical implication is this: when a peptide serum is delivered simultaneously through micro-channels rather than applied to intact skin, the available evidence suggests a meaningful improvement in how much of the active ingredient reaches the viable skin layers, compared to topical application alone.

 

This is the scientific rationale behind formulating a serum specifically for micro-channel delivery rather than general topical use, and calibrating that formulation to a molecular weight and viscosity suited to simultaneous application through a 0.5mm device.

 

A Note on What Topical Peptides Do Well

 

 

In the interest of a balanced and accurate picture, it is worth reiterating where topical peptides remain highly effective regardless of delivery method.

 

Shorter chain peptides with lower molecular weights, particularly dipeptides and tripeptides, are small enough to show meaningful penetration through intact skin in well-designed formulations. Signal peptides that operate at the surface of skin cells do not require deep penetration to initiate their effect. And lipophilic modifications, such as the palmitoyl chain on Palmitoyl Tripeptide-1, genuinely improve barrier crossing for the peptides they are bonded to.

 

The point is not that topical application is ineffective. It is that micro-channel delivery represents a more efficient pathway for peptides that would otherwise be limited by molecular size or polarity. For a serum containing multiple peptide types, including larger and more hydrophilic molecules, the combination of micro-channel delivery and well-formulated ingredients produces a more complete result than either approach alone.

 

 

 

Erra Skin is an Australian cosmetic skincare brand specialising in at-home micro-infusion. The Erra Skin Micro-Infusion Kit is a cosmetic device intended for appearance enhancement only. This post references published independent research for educational purposes. It does not constitute medical advice and does not make therapeutic claims about the Erra Skin device.

 

RELATED READING

Why Peptides Belong Inside Your Skin, Not Just On Top Of It

Derma Roller vs Micro Infusion: Why One Changed My Skin and One Didn’t